A made-to-order DNA vaccine takes aim at liver cancer's return
⭐️ VACCINE ⭐️
Not yet recruiting
This phase II trial tests whether a personalized DNA vaccine, tailored to each patient's tumor, can keep high-risk liver cancer from coming back after surgical removal. Participants who have no remaining signs of cancer after surgery will receive the vaccine plus an immune booste…
Phase: PHASE2 • Sponsor: Geneos Therapeutics • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 16, 2026 00:00 UTC